Skip to main content
FinSpry Logo
FinSpry
ABEO logo
ABEO
(NASDAQ)
Abeona Therapeutics Inc.
$5.56-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Abeona Therapeutics (ABEO) Stock Price & Financial Analysis

Abeona Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$5.54 - $5.75
52-Week High$7.54
52-Week Low$4.00
Open$5.65
Volume1.58M
Average Volume (3M)1.08M
Market Cap318.21M
Shares Outstanding56.62M
P/E Ratio (TTM)4.81
Price to Sales (P/S)21.89
Price to Book (P/B)2.20
EV/EBITDA3.81
Revenue (TTM)14.54M
Net Income (TTM)66.14M
Free Cash Flow (TTM)-85.24M
EPS (TTM)$1.09
Profit Margin454.86%
Operating Margin-637.92%
Return on Equity (ROE)45.63%
Debt to Equity0.16
50-Day MA$5.57
200-Day MA$5.22
52-Week Change-4.10%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Last Dividend Ex-DateMar 31, 2000

Frequently Asked Questions About Abeona Therapeutics

What is the current stock price for ABEO?

As of the latest trading session, ABEO stock trades at $5.56. The 52-week range is $4.00–$7.54, with a day range of $5.54–$5.75.

What is the P/E ratio for ABEO?

Abeona Therapeutics's trailing P/E ratio is 4.8, meaning investors pay $4.8 for every $1 of annual earnings. Abeona Therapeutics operates in the Healthcare sector.

Does ABEO pay dividends?

Abeona Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ABEO?

Based on 4 analysts, the consensus for ABEO is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ABEO?

Abeona Therapeutics's market capitalization is $314.8M, classifying it as a small-cap company. Abeona Therapeutics operates in the Healthcare sector within the Biotechnology industry.